Comparative Radiologic Outcomes of Romosozumab and Teriparatide in Osteoporotic Vertebral Fractures
Open Access
- 19 March 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2349
Abstract
Background/Objectives: Osteoporotic vertebral fractures (OVFs) are frequently associated with progressive kyphotic deformity and vertebral height loss, adversely affecting spinal alignment and function. Although romosozumab and teriparatide are established anabolic therapies, comparative data on their longitudinal radiologic effects after OVFs remain limited. This study compared radiologic and clinical outcomes between these agents in patients with OVFs. Methods: Sixty-two patients with single-level OVFs were included: 34 patients in the romosozumab group and 28 patients in the teriparatide group, analyzed in a retrospective, observational comparative study. All patients received anabolic therapy for 6 months followed by sequential denosumab. Radiologic parameters (Cobb angle, vertebral wedge angle, and anterior and middle vertebral body heights) were evaluated at baseline and at 1, 3, 6, and 12 months. Bone mineral density (BMD) and clinical outcomes were assessed at baseline and 12 months. Results: Baseline characteristics were comparable between groups. No statistically significant between-group differences were observed in radiologic parameters over 12 months. However, the romosozumab group showed numerically smaller increases in kyphotic angles and less vertebral height loss, particularly beyond 6 months. Lumbar spine BMD increased in both groups, with a greater absolute gain in the romosozumab group. Back pain improved substantially in both groups, while disability improvement was greater in the teriparatide group. Conclusions: Romosozumab and teriparatide demonstrated comparable radiologic and clinical outcomes in OVFs. Although differences were not statistically significant, romosozumab showed a numerical trend toward better preservation of spinal alignment and vertebral height.Keywords
Funding Information
- Catholic Medical Center Research Foundation (5-2024-B0001-00077)
- National Research Foundation of Korea (RS-2025-24683650)
This publication has 40 references indexed in Scilit:
- Conservative Treatments in the Management of Acute Painful Vertebral Compression FracturesJAMA Network Open, 2024
- Surgery for spinal deformity with osteoporosis: Achieving successful fusionOsteoporosis and Sarcopenia, 2024
- Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative reviewOsteoporosis International, 2024
- Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment GoalsJBMR Plus, 2021
- Persistence and adherence to parenteral osteoporosis therapies: a systematic reviewOsteoporosis International, 2020
- Effects of anti-osteoporosis medications on radiological and clinical results after acute osteoporotic spinal fractures: a retrospective analysis of prospectively designed studyOsteoporosis International, 2019
- Romosozumab for the treatment of osteoporosisOsteoporosis and Sarcopenia, 2018
- Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and Pain ScalesThe Spine Journal, 2008
- Trabecular bone fracture healing simulation with finite element analysis and fuzzy logicJournal of Biomechanics, 2005
- The clinical consequences of vertebral compression fractureBone, 1992